Pakarinen P, Lähteenmäki P, Rutanen E M
Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Institute of Biomedicine, University of Helsinki, Finland.
Acta Obstet Gynecol Scand. 1999 May;78(5):423-8.
The concentrations of sex hormone-binding globulin (SHBG) have been shown to decrease during the use of levonorgestrel (LNG)-containing contraception. This decrease has been thought to be due to the androgenic action of LNG. In endogenously hyperandrogenic women, particularly in those with increased body weight, serum SHBG correlates with circulating insulin-like growth factor binding protein-1 (IGFBP-1) concentration, and both are inversely related to insulin. LNG-containing combined contraceptives have also been reported to increase the pancreatic insulin secretion.
To examine whether serum insulin and IGFBP-1 levels are related to SHBG during the use of intrauterine or oral levonorgestrel contraception.
Thirty-one fertile women were divided into three study groups: A copper-releasing intrauterine device (IUD) was inserted in control group (n= 10), and the LNG-releasing intrauterine contraceptive system (LNG-IUS) in group II (n= 10), and 30 mirog LNG-containing contraceptive minipills were given in group III (n=11). Twenty-nine women completed the study and one woman was excluded because of a high body mass index. Fasting concentrations of blood glucose, insulin, SHBG, IGFBP-1, testosterone and LNG before and after three-months-use of contraception were measured.
SHBG concentrations decreased slightly during oral LNG contraception, but not during the use of the LNG-IUS. No change was found in blood glucose, serum insulin, serum IGFBP-1 and serum total testosterone concentrations in either group. In our study group, including women with normal body weight, no correlation was detected between insulin and SHBG concentrations before or after LNG contraception, whereas an inverse correlation was found between insulin and IGFBP-1 levels at the baseline as well as after LNG-IUS use (R2= 0.578; p=0.001). Multiple regression analysis showed no significant association between the levels of SHBG and IGFBP-1 as dependent factors, and glucose, insulin, LNG, age, waist-hip ratio and body mass index as dependent factors.
Our data imply that the effect of levonorgestrel on variables associated with endogenous hyperandrogenism remains borderline in women with normal body mass index.
已表明在使用含左炔诺孕酮(LNG)的避孕方法期间,性激素结合球蛋白(SHBG)的浓度会降低。这种降低被认为是由于LNG的雄激素作用。在内源性雄激素过多的女性中,尤其是体重增加的女性,血清SHBG与循环胰岛素样生长因子结合蛋白-1(IGFBP-1)浓度相关,且两者均与胰岛素呈负相关。含LNG的复方避孕药也被报道会增加胰腺胰岛素分泌。
研究在使用宫内或口服左炔诺孕酮避孕期间,血清胰岛素和IGFBP-1水平与SHBG是否相关。
31名有生育能力的女性被分为三个研究组:对照组(n = 10)放置含铜宫内节育器(IUD),第二组(n = 10)放置含LNG的宫内避孕系统(LNG-IUS),第三组(n = 11)服用30 μg含LNG的避孕迷你片。29名女性完成了研究,一名女性因体重指数高被排除。在使用避孕方法三个月前后,测量空腹血糖、胰岛素、SHBG、IGFBP-1、睾酮和LNG的浓度。
口服LNG避孕期间SHBG浓度略有下降,但使用LNG-IUS期间未下降。两组的血糖、血清胰岛素、血清IGFBP-1和血清总睾酮浓度均未发现变化。在我们的研究组中,包括体重正常的女性,在LNG避孕前后,胰岛素与SHBG浓度之间未检测到相关性,而在基线时以及使用LNG-IUS后,胰岛素与IGFBP-1水平之间发现呈负相关(R2 = 0.578;p = 0.001)。多元回归分析显示,以SHBG和IGFBP-1水平为因变量,以血糖、胰岛素、LNG、年龄、腰臀比和体重指数为自变量,两者之间无显著关联。
我们的数据表明,对于体重指数正常的女性,左炔诺孕酮对与内源性雄激素过多相关变量的影响仍不明确。